Mind Body Intervention for Long COVID-19
Mind Body Intervention for Long COVID
Beth Israel Deaconess Medical Center
180 participants
Nov 9, 2023
INTERVENTIONAL
Conditions
Summary
The goal of this study is to determine if a mind-body intervention can help people suffering from symptoms associated with Long COVID. The study is a randomized trial examining the effectiveness of a mind body intervention in reducing somatic symptoms from Long COVID in participants as compared to usual care and an active control (second mind body intervention). The investigators will secondarily investigate whether the intervention alleviates individual somatic complaints and improves daily functioning, relative to usual care and the active control
Eligibility
Inclusion Criteria6
- Adult (≥ 18 years of age)
- Infection with Sars-COV2 (i. e., positive antibody, antigen, or PCR testing)
- Symptoms attributed only to COVID-19 and not to known comorbid disease (e.g., other infections, cancer, etc)
- A somatic symptom score ≥ 10 on the SSS-8 questionnaire with involvement of at least 3 domains
- Symptoms present at least 3 day a week for a minimum of 3 months
- Willingness to engage in a Mind-Body intervention
Exclusion Criteria6
- Clear diagnosis of physical disease (e.g. lung fibrosis, myocarditis) not inclusive of non-specific findings such as mild arthritis
- Hospitalization in an intensive care unit for acute COVID-19 infections
- Age greater than 65 years
- Diagnosis of dementia or similar cognitive impairment
- Active addiction disorder (e.g. cocaine) that would interfere with study participation
- Major psychiatric comorbidity (e.g., schizophrenia). Mild to moderate anxiety and depression are not considered in this category
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
The mind-body intervention will include regular 1 to 2 hour educational sessions and lectures, as well as supplemental reading material. In addition, individualized sessions will be offered each week for students who have additional questions and/or need additional time with the material.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06045338